Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baroreflex Sensitivity in Patients Undergoing Atrial Fibrillation Ablation: Association With Arrhythmia Recurrences

NCT04503122 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT04503122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04503122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baroreflex Sensitivity in Patients Undergoing Atrial Fibrillation Ablation: Association With Arrhythmia Recurrences
Lead sponsor
Poitiers University Hospital
Phase
Observational
Overall status
Completed
Start date
June 22, 2021
Completion date
November 13, 2025
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation